ZSQ836 is an orally active dual covalent inhibitor of CDK12/CDK13 , with an EC 50 value of 32 nM against CDK12 . ZSQ836 can induce apoptosis and exhibit anticancer activity in vivo . ZSQ836 can be used in the study of ovarian cancer .
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > CDK
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。